207 related articles for article (PubMed ID: 8134122)
61. Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level.
Giuliani C; Napolitano G; Mastino A; Di Vincenzo S; D'Agostini C; Grelli S; Bucci I; Singer DS; Kohn LD; Monaco F; Garaci E; Favalli C
Eur J Immunol; 2000 Mar; 30(3):778-86. PubMed ID: 10741392
[TBL] [Abstract][Full Text] [Related]
62. Repression of MHC class II gene transcription in trophoblast cells by novel single-stranded DNA binding proteins.
Murphy SP; Gollnick SO; Pazmany T; Maier P; Elkin G; Tomasi TB
Mol Reprod Dev; 1997 Aug; 47(4):390-403. PubMed ID: 9211423
[TBL] [Abstract][Full Text] [Related]
63. Modification of histocompatibility antigen expression in cells expressing activated oncogenes: implications for tumour development.
Morris A
Anticancer Res; 1990; 10(5A):1161-7. PubMed ID: 2122794
[TBL] [Abstract][Full Text] [Related]
64. MHC regulation in neural cells. Distribution of peripheral and internal beta 2-microglobulin and class I molecules in human neuroblastoma cell lines.
Lampson LA
J Immunol; 1990 Jan; 144(2):512-20. PubMed ID: 2104897
[TBL] [Abstract][Full Text] [Related]
65. The expression of major histocompatibility antigens under metallothionein gene promoter control.
Weis JH; Seidman JG
J Immunol; 1985 Mar; 134(3):1999-2003. PubMed ID: 3918115
[TBL] [Abstract][Full Text] [Related]
66. Expression of major histocompatibility complex (MHC) class I genes in astrocytes correlates with the presence of nuclear factors that bind to constitutive and inducible enhancers.
Massa PT; Hirschfeld S; Levi BZ; Quigley LA; Ozato K; McFarlin DE
J Neuroimmunol; 1992 Nov; 41(1):35-42. PubMed ID: 1460091
[TBL] [Abstract][Full Text] [Related]
67. NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse.
Hamaguchi K; Gaskins HR; Leiter EH
Diabetes; 1991 Jul; 40(7):842-9. PubMed ID: 1647994
[TBL] [Abstract][Full Text] [Related]
68. Evidence for the involvement of a nuclear NF-kappa B inhibitor in global down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells.
Liu X; Ge R; Ricciardi RP
Mol Cell Biol; 1996 Jan; 16(1):398-404. PubMed ID: 8524321
[TBL] [Abstract][Full Text] [Related]
69. Functional pancreatic beta-cell line from SV40 T-antigen transgenic mouse.
Gilligan A; Jewett L; Simon D; Damjanov I; Matschinsky FM; Weik H; Pinkert C; Knowles BB
Diabetes; 1989 Aug; 38(8):1056-62. PubMed ID: 2502459
[TBL] [Abstract][Full Text] [Related]
70. Comparison of cytokine effects on mouse pancreatic alpha-cell and beta-cell lines. Viability, secretory function, and MHC antigen expression.
Hamaguchi K; Leiter EH
Diabetes; 1990 Apr; 39(4):415-25. PubMed ID: 2108069
[TBL] [Abstract][Full Text] [Related]
71. Differential expression of the H-2Dk MHC class-I antigen and tissue inhibitor of metalloproteinases in metastatic and nonmetastatic T-10 fibrosarcoma cells.
Har-Vardi I; Gopas J; Rager-Zisman B; Hammerling GJ; Segal S; Aboud M
Invasion Metastasis; 1992; 12(5-6):301-8. PubMed ID: 1298741
[TBL] [Abstract][Full Text] [Related]
72. Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters.
Melloul D; Ben-Neriah Y; Cerasi E
Proc Natl Acad Sci U S A; 1993 May; 90(9):3865-9. PubMed ID: 8483904
[TBL] [Abstract][Full Text] [Related]
73. Transfected rat islet tumour cells express mouse major histocompatibility complex class I antigens functionally. Applicable as "pseudo-syngeneic" targets in the multiple low-dose streptozotocin diabetes model.
Serup P; Schøller J
Diabetologia; 1989 Jul; 32(7):409-15. PubMed ID: 2553516
[TBL] [Abstract][Full Text] [Related]
74. Suppression of anchorage-independent growth of human glioblastoma cell by major histocompatibility complex class I gene-transfection.
Momozaki N; Oh-Uchida M; Tabuchi K; Ikezaki K; Hori K
J Neurosurg; 1992 May; 76(5):845-9. PubMed ID: 1564545
[TBL] [Abstract][Full Text] [Related]
75. Defective E beta expression in three mouse H-2 haplotypes results from aberrant RNA splicing.
Tacchini-Cottier FM; Jones PP
J Immunol; 1988 Nov; 141(10):3647-53. PubMed ID: 2460544
[TBL] [Abstract][Full Text] [Related]
76. DNA binding of regulatory factors interacting with MHC-class-I gene enhancer correlates with MHC-class-I transcriptional level in class-I-defective cell lines.
Blanchet O; Bourge JF; Zinszner H; Tatari Z; Degos L; Paul P
Int J Cancer Suppl; 1991; 6():138-45. PubMed ID: 1906051
[TBL] [Abstract][Full Text] [Related]
77. Modulation by glycyrrhizin of the cell-surface expression of H-2 class I antigens on murine tumour cell lines and normal cell populations.
Zhang YH; Yoshida T; Isobe K; Rahman SM; Nagase F; Ding L; Nakashima I
Immunology; 1990 Jul; 70(3):405-10. PubMed ID: 1696243
[TBL] [Abstract][Full Text] [Related]
78. Decline in MHC class I expression with increasing thickness of cutaneous melanomas in standard-strain transgenic mouse models.
Milling SW; Silvers WK; Sai T; Mintz B
Melanoma Res; 2002 Jun; 12(3):221-30. PubMed ID: 12140378
[TBL] [Abstract][Full Text] [Related]
79. Effect of mouse interferon on the expression of a porcine major histocompatibility gene introduced into mouse L cells.
Satz ML; Singer DS
J Immunol; 1984 Jan; 132(1):496-501. PubMed ID: 6690608
[TBL] [Abstract][Full Text] [Related]
80. Multiple levels of MHC class I down-regulation by ras oncogenes.
Lohmann S; Wollscheid U; Huber C; Seliger B
Scand J Immunol; 1996 May; 43(5):537-44. PubMed ID: 8633212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
